Loading the company…
Loading the company…
Families: Hysterectomy, hysteroscopy & ablation.
All companies · Product and company coverage
In the last ten years FDA made 22 decisions for Axora Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2017 (5). The latest was on 2026-08-18.
| Family | Decisions on record |
|---|---|
| Hysterectomy, hysteroscopy & ablation | 62 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-08-18 | 510(k) | K260984 | HERizon RD5 Resecting Device (5FR1PK);HERizon RD5 Resecting Device - 5 pack (5FR5PK) |
| 2026-02-12 | PMA | P140013-S018 | Minerva Endometrial Ablation System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2025-04-14 | PMA | P140013-S016 | Minerva Endometrial Ablation System · Location Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2024-12-05 | PMA | P140013-S017 | Minerva ES Endometrial Ablation System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2024-01-24 | PMA | P140013-S015 | Minerva Endometrial Ablation System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Axora Medical.